018828179

ETHRIS

---

January 23, 2023

Trademark Summary

The trademark application ETHRIS was filed by Ethris GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on January 30, 2023, and it was registered by office on May 9, 2023 without any oppositions.

It was designated 'Basic Application' for International Application 1759460 at the World Intellectual Property Organization (WIPO).

The application was filed in English (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on June 20, 2023.

The application claimed as seniority of the Federal Republic of Germany trademark 3020090511500 registered on January 7, 2010 and filed on August 26, 2009 which was accepted by the office.

---

Goods And Services

• The mark was filed in class 1 with following description of goods:
  
  1. Preservatives for pharmaceuticals
  2. Chemical substances, chemical materials and chemical preparations, and natural elements
  3. Detergents for use in manufacture and industry
  4. Salts for industrial purposes
  5. Chemical and organic compositions for use in the manufacture of food and beverages
  6. Aqueous chemical compositions
  7. Triglycerides
  8. Nucleic recombinant acids
  9. Nucleic acids
  10. Nucleic acids for scientific purposes
  11. Pyrimidine
  12. Lipids for use in manufacture
  13. Hydrosoluble polymers
  14. Polymer dispersions
  15. Biodegradable polymer compositions
  16. Hydrogel polymer coatings
  17. Cationic polymers
  18. Polymer solutions
  19. Aqueous polymer dispersions
  20. Fatty acid esters.
• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals
  2. Pharmaceutical drugs
  3. Dermatological pharmaceutical products
  4. Pharmaceutical preparations
  5. Dermatological pharmaceutical substances
  6. Pharmaceutical compositions
  7. Antidiabetic pharmaceuticals
  8. Anti-diabetic pharmaceuticals
  9. Cardiovascular pharmaceuticals
  10. Injectable pharmaceuticals
  11. Tissue-regenerative pharmaceutical preparations
  12. Cardiovascular pharmaceutical preparations
  13. Antibacterial pharmaceuticals
  14. Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
  15. Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
  16. Anaesthetic preparations for inhalation
  17. Pharmaceutical preparations for inhalers
  18. Sanitary preparations and articles
  19. Hygienic preparations and articles
  20. Air deodorising and air purifying preparations
  21. Dental preparations and articles
  22. Dental preparations and articles, and medicated dentifrices
  23. Dietary supplements and dietetic preparations
  24. Pest control preparations and articles
  25. Pharmaceutical preparations for the treatment of kidney diseases
  26. Respiratory stimulants
  27. Compounds for treating correlated pulmonary syndromes
  28. Medicines for the treatment of cardiovascular and cerebrovascular diseases
  29. Fertility enhancement preparations
  30. Pharmaceutical preparations for regulating the immune system
  31. Pharmaceutical preparations for the prevention of diseases of the immune system
  32. Pharmaceutical preparations for the prevention of disorders of the immune system
  33. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
  34. Pharmaceutical preparations for the treatment of autoimmune diseases
  35. Pharmaceutical preparations for the prevention of autoimmune diseases
  36. Pharmaceutical preparations for the treatment of autoimmune disorders
  37. Pharmaceutical preparations for the prevention of autoimmune disorders
  38. Autoantigens
  39. Vaccines
  40. Vaccine preparations
  41. Vaccine adjuvants
  42. Veterinary vaccines
  43. Vaccines against pneumococcal infections
  44. Viral vaccines
  45. Human vaccine preparations
  46. Vaccines against flu
  47. Oral vaccine preparations
  48. Antiviral drugs for treating influenza
  49. Vaccines for human use
  50. Fat emulsions for medical infusions
  51. Medical preparations
  52. Medicinal healthcare preparations
  53. Medicinal infusions
  54. Infusions (Medicinal -)
  55. Medicinal preparations and substances
  56. Medicine
  57. Serotherapeutic medicines
  58. Antiallergic medicines
  59. Medicines for animals
  60. Nucleic acid sequences for medical and veterinary purposes
  61. Acids for pharmaceutical purposes
  62. Adjuvants for medical purposes
  63. Cellular function activating agents for medical purposes
  64. Chemical preparations for medical purposes
  65. Chemical preparations for veterinary purposes
  66. Nasal sprays for medical purposes
  67. Medicated nasal spray preparations
  68. Pharmaceutical preparations for the treatment of cancer
  69. Biological preparations for the treatment of cancer
  70. Biopharmaceuticals for the treatment of cancer
  71. Pharmaceutical products for the treatment of cancer
  72. Pharmaceutical preparations and substances for the treatment of cancer
  73. Pharmaceutical preparations and substances for the prevention of cancer
  74. Compounds for treating cancer
  75. Pharmaceutical preparations for activating cellular function.
• The mark was filed in class 42 with following description of goods:
  
  1. Research of pharmaceuticals
  2. Pharmaceutical drug development services
  3. Development of pharmaceutical preparations and medicines
  4. Research and development of vaccines and medicines
  5. Vaccine research and development services
  6. Research and development services relating to vaccines
  7. Development of gene-based medicines.
• The mark was filed in class 44 with following description of goods:
  
  1. Preparation and dispensing of medications
  2. Fertility treatment
  3. Human fertility treatment services
  4. Vaccination services
  5. Regenerative medicine services
  6. Dispensing of pharmaceuticals.